CD8A and myeloid sarcoma: Specifically, CD8+ T cells from healthy human donors as well MS patients during disease quiescence can suppress CD4+ T cell proliferation in vitro, whereas CD8+ T cells during disease exacerbation show impaired suppressive capacity [17–19].